CLINICAL TRIALS PROFILE FOR CADUET

All Clinical Trials for Caduet

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00150384 ↗	Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population	Completed	Pfizer	Phase 4	2004-07-01	The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population
NCT00150384 ↗	Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2004-07-01	The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population
NCT00332761 ↗	Caduet in an Untreated Subject Population	Completed	Pfizer	Phase 4	2006-06-01	The purpose of this study is to determine if Caduet will lower blood pressure to <140/90 mmHg and lower LDL Cholesterol to <100 mg/dL in subjects with hypertension and dyslipidemia who are not currently being treated for these medical conditions.
NCT00332761 ↗	Caduet in an Untreated Subject Population	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2006-06-01	The purpose of this study is to determine if Caduet will lower blood pressure to <140/90 mmHg and lower LDL Cholesterol to <100 mg/dL in subjects with hypertension and dyslipidemia who are not currently being treated for these medical conditions.

Clinical Trial Conditions for Caduet

Condition Name

Condition Name for Caduet
Intervention	Trials
Hypertension	7
Dyslipidemia	3
Hypercholesterolemia	3
Angina Pectoris	2

Condition MeSH

Condition MeSH for Caduet
Intervention	Trials
Hypertension	5
Dyslipidemias	4
Hypercholesterolemia	3
Angina Pectoris	2

Clinical Trial Locations for Caduet

Trials by Country

Trials by Country for Caduet
Location	Trials
United States	66
Japan	8
Mexico	4
Venezuela	3
Korea, Republic of	3

Trials by US State

Trials by US State for Caduet
Location	Trials
Georgia	3
California	3
Virginia	3
Texas	3
Tennessee	3

Clinical Trial Progress for Caduet

Clinical Trial Phase

Clinical Trial Phase for Caduet
Clinical Trial Phase	Trials
Phase 4	9
Phase 1	2

Clinical Trial Status

Clinical Trial Status for Caduet
Clinical Trial Phase	Trials
Completed	9
Unknown status	3
Terminated	1

Clinical Trial Sponsors for Caduet

Sponsor Name

Sponsor Name for Caduet
Sponsor	Trials
Pfizer	8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	7
Dr. Reddy's Laboratories Limited	2

Sponsor Type

Sponsor Type for Caduet
Sponsor	Trials
Industry	17
Other	5